Loading...
Trimetazidine does not modify blood levels and immunosuppressant effects of cyclosporine A in renal allograft recipients
Aims In renal allograft recipients, trimetazidine (Vastarel(®) ) was proposed to be associated with the classic immunosuppressant treatments because it displays anti-ischaemic effects which may protect against cyclosporine A nephrotoxicity. The objective of this work was to assess the possibility of...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
1997
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2042879/ https://ncbi.nlm.nih.gov/pubmed/9431838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.1997.t01-1-00628.x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|